BioPharmX taps KIP's Wang for board

Silicon Valley-based biotech firm BioPharmX Corp. has named Ping Wang to its board of directors. Wang is a principal at Korea Investment Partners.

10 November 2014•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles